Tag
Bhavesh Patel
5 articles
Amanta Healthcare has scheduled an earnings conference call for May 19, 2026, at 3:30 PM IST to discuss its Q4 and full-year FY26 financial performance. Key management participants, including MD Bhavesh Patel and CFO Paras Mehta, will join the call, which requires prior registration. Recent filings also reveal clarifications regarding promoter share acquisitions by Bhavesh Patel. Initially, a disclosure indicated the acquisition of 28,800 shares, but this was later corrected to 13,300 shares, with the remaining 15,500 shares being rejected due to technical transfer issues. Patel's total stake now stands at 63,26,544 shares, representing 16.29% of the company.
Amanta Healthcare Q4 FY26 PAT Rises 28% YoY
Amanta Healthcare reported Q4 FY26 revenue of INR77 crore and a 28% YoY PAT increase to INR5.5 crore, with full-year revenue at INR288 crore.
The company is expanding SteriPort IV fluid capacity from
Amanta Healthcare Q4 & FY26 Results Announcement
Amanta Healthcare reported FY26 revenue of ₹288 crore, a 5% YoY increase, with PAT surging 42% YoY to ₹15 crore.
Q4FY26 revenue grew 7% YoY to ₹77 crore, while PAT increased 28% YoY to ₹5.5 crore due
Amanta Healthcare Promoter Bhavesh Patel Share Acquisition Clarification
Amanta Healthcare clarifies credit of 15,500 shares to promoter Bhavesh Patel's demat account on April 17, 2026.
Revised promoter holding increases to 63,26,544 shares (16.29%) from previous 63,11,044
Amanta Healthcare Clarifies Promoter Share Acquisition Discrepancy
Amanta Healthcare submits a clarification to BSE and NSE regarding a prior disclosure about promoter share acquisition.
The company corrects that only 13,300 shares were credited to promoter Bhavesh P
Amanta Healthcare Promoter Buys 28,800 Shares
Amanta Healthcare discloses Form C under SEBI Insider Trading Regulations for open market purchase by promoter.
Shri Bhavesh Patel, Promoter, CMD, acquired 28,800 equity shares on March 27 and March 3